Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

Part of paid clinical trials in Los Angeles, California.

Sponsor
Children's Hospital Los Angeles
Study ID
NCT00870636
Status
No Longer Available

Conditions

  • Retinopathy of Prematurity

Eligibility Criteria

Sex
ALL
Age
30 Weeks - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to provide access to intravitreal injection of Avastin in high-risk infants who do not otherwise qualify for study NCT00702819, an investigational multi-site study examining Avastin use for retinopathy of prematurity.

Key Dates

First listed
Mar 27, 2009
Status verified
Nov 2023

Locations (1)

FacilityCityStateZIPSite coordinators
Childrens Hospital Los AngelesLos AngelesCalifornia90027-

Find similar trials in Los Angeles, CA

By research site
Childrens Hospital Los Angeles· Los Angeles, CA

Related Studies